Chapter 9 - THE PATENTS HE NEVER TOLD RACHEL ABOUT
Rachel did not know Lily owned valuable patent rights.
That sounded impossible.
Then Halston Legal explained.
Peter Morgan’s estate had been poorly handled.
He died suddenly.
No sophisticated planning.
Most assets passed through probate.
Patent interests were listed in technical language.
Rachel, twenty-nine at the time, grieving and raising a five-year-old, signed documents she barely understood.
Halston continued paying small annual royalties into an estate account.
Nothing dramatic.
Until the patents exploded in value.
Three years later, Halston planned to expand licensing internationally.
Daniel knew.
He worked in strategy.
He also knew that before certain licensing amendments could be finalized, the company needed consent from minority patent-interest holders.
Lily’s estate mattered.
Suddenly Daniel’s interest in Rachel looked different.
When had the affair begun?
Rachel answered.
Fourteen months earlier.
When had Daniel first been assigned to the international patent expansion?
Fifteen months earlier.
One month before.
I felt cold.
Rachel did too.
“You think he targeted me?”
“I don’t know.”
“I met him because he asked me to coordinate meetings.”
That was normal for a secretary.
Then private lunches.
Gifts.
Emotional confidences.
Affair.
Townhouse.
Benefits.
Daniel had created dependence around the person controlling Lily’s rights.
Why?
Halston Legal found drafts.
A patent-interest assignment.
Rachel Morgan, as guardian for Lily, would assign certain royalty rights to Carter Legacy Partners in exchange for education funding and housing.
Had Rachel signed?
No.
Not yet.
But Daniel had prepared it.
Zurich meeting.
That was probably why they were going.
Private bank.
Trust.
Patent rights.
Move everything into one structure.
My newborn son as family legitimacy.
Lily’s patents as cash-producing asset.
Rachel as administrator.
Daniel as controller.
And me?
Gone eventually.
Maybe through divorce.
Maybe through financial exclusion.
No need for melodrama.
He simply planned a future in which I had become irrelevant.
Then Halston found something worse.
Daniel had already represented internally that Lily’s estate intended to assign the patent interests.
Based on what authorization?
A consent letter.
Signed:
Rachel Morgan.
Rachel stared at the copy.
“I never signed this.”
Another forged signature.
Daniel’s system was simple:
If reality did not cooperate, create paperwork until it looked like it did.
Then Robert Halston called me personally.
First time.
“Sophie.”
“Robert.”
“I owe you an apology.”
“For Daniel?”
“No.”
He sounded exhausted.
“For the company.”
I said nothing.
“We had controls. He learned where they were weak.”
“That isn’t your fault alone.”
“No. But leadership owns systems.”
I respected that.
Then he said:
“We found another transaction involving your family.”
My stomach tightened.
“What?”
“HCT purchased shares.”
“In Halston?”
“No.”
He paused.
“In a biotech company.”
Name:
Asterion Pediatric Systems.
I knew it.
They manufactured neonatal monitoring equipment.
Noah had spent his first night after birth connected to one of their monitors because of transient breathing concerns.
“What does Daniel have to do with Asterion?”
Robert answered:
“HCT bought six percent.”
“How much?”
“Almost four million dollars.”
I almost laughed.
“HCT didn’t have four million.”
“No.”
Robert’s voice went cold.
“Halston did.”
Daniel had diverted far more money than anyone originally knew.
May you like
And according to the purchase documents, the shares were held for a trust with one beneficiary.
Noah Carter.
